Rezolute RZLT
NASDAQ RZLT
$4.01 -0.06 (-1.47%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rezolute (RZLT) Depreciation & Amortization - Total (2014)

Updated

Rezolute (RZLT) posted Depreciation & Amortization - Total of $27,395 for fiscal Q1 2015 (quarter ended Sep 30, 2014).

Analysis

Rezolute (RZLT) Depreciation & Amortization - Total (2014) Analysis & Trends

For FY2014 (ended Jun 30, 2014), Rezolute's Depreciation & Amortization - Total came in at $7,759.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Rezolute 386.59 Mn 386.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 27,395.00
API Access

Rezolute Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=RZLT&period=max&api_key=YOUR_API_KEY